We create
a healthy future

Research and development

Pharmacovigilance

since

2001

at the pharmaceutical
market

№1

in the Russian
insulin market

more than

1600

highly skilled
employees

more than

160

million USD
total investment into
technological innovation
and R&D in the last 10 years

International rapidly growing biotechnological company with all insulin blockbusters in its portfolio

Our mission

Values of the company

Ambition

these are ideas created by our brain that allow us to surpass ourselves

Passion

creates a fire in our heart

Responsibility

it's our hands that finish the job

Drugs

Company portfolio

Neurology.
Psychiatry

Scientific developments

Scientific developments

Scientific developments

Own research center
performs a full development cycle: from the molecule
before registration of the drug. Biotech development
drugs - the priority of the company.

Scientific developments

Location: Special Economic Zone in St. Petersburg (Neudorf site)

Area: over 1,500 sq. m.

Full-cycle development of medicinal products in accordance with GLP, GCP, GMP

In the near future -
full line release
biosimilars of insulin

Manufacture

Saint Petersburg, Pushkin

Production of active pharmaceutical substances. After reaching the design capacity the company will be able to cover Russian needs in insulin for 100 % and to expand export opportunities

Moscow Region, Obolensk

A leading full-cycle producer of gene-engineering human insulin – from synthesis of a substance to finished dosage form. The plant can cover 30 % of Russian needs in insulin

News

Company news

22.06.2025

The delegation from Myanmar got acquainted with the manufacturing site of GEROPHARM in Pushkin

19.06.2025

Uzbekistan’s Vice Prime Minister Visits GEROPHARM’s Plant in Pushkin

26.05.2025

GEROPHARM and R-PHARM Pharmaceutical Plant in Azerbaijan Sign Partnership Agreement for Insulin Localisation

16.05.2025

GEROPHARM and FEFU Launched the First Russia-China Industrial Biomedicine and Pharmaceutics Institute

Go up